483
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Awareness of healthcare professionals about risk minimization measures associated with COVID-19 vaccines: international cross-sectional study

, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2252106 | Received 24 May 2023, Accepted 22 Aug 2023, Published online: 06 Sep 2023

Figures & data

Table 1. Demographic data summary.

Table 2. Summary of the countries that participated in the international part of the study.

Figure 1. Q1: Do you accept pharmacists to take part in campaigns for increasing population’s awareness concerning the administration of the compulsory immunizations and reimmunizations as per the immunization calendar of your country?

Figure 1. Q1: Do you accept pharmacists to take part in campaigns for increasing population’s awareness concerning the administration of the compulsory immunizations and reimmunizations as per the immunization calendar of your country?

Figure 2. Q3: Have you ever got infected with COVID-19?

Figure 2. Q3: Have you ever got infected with COVID-19?

Figure 3. Q4: Have you been hospitalized during the infection?

Figure 3. Q4: Have you been hospitalized during the infection?

Figure 4. Q6: Have you been vaccinated?

Figure 4. Q6: Have you been vaccinated?

Figure 5. Q5: Are you familiar with the fact that vaccines against COVID-19 have received conditional marketing authorization on the territory of EU for a period of 1 (one) year?

Figure 5. Q5: Are you familiar with the fact that vaccines against COVID-19 have received conditional marketing authorization on the territory of EU for a period of 1 (one) year?

Figure 6. Q10: As an HCP, would you recommend vaccination to your patients?

Figure 6. Q10: As an HCP, would you recommend vaccination to your patients?

Figure 7. Q12: Would you recommend vaccination to your patients more confidently if vaccines have marketing authorization valid for 5 (five) years?

Figure 7. Q12: Would you recommend vaccination to your patients more confidently if vaccines have marketing authorization valid for 5 (five) years?

Figure 8. Q11: Do you consider yourself familiar enough with the most frequent ADRs (adverse drug reactions) after administration of a COVID-19 vaccine?

Figure 8. Q11: Do you consider yourself familiar enough with the most frequent ADRs (adverse drug reactions) after administration of a COVID-19 vaccine?

Figure 9. Q16: Do you agree with the statement that the vaccines authorized for use in EU are ‘of high quality, efficacious and safe’?

Figure 9. Q16: Do you agree with the statement that the vaccines authorized for use in EU are ‘of high quality, efficacious and safe’?

Figure 10. Q14: Do you consider that you need additional professional data for the vaccines authorized for use in EU?

Figure 10. Q14: Do you consider that you need additional professional data for the vaccines authorized for use in EU?

Figure 11. Q13: Are you familiar with the content of ‘risk minimization plan’ of the vaccines authorized for use?

Figure 11. Q13: Are you familiar with the content of ‘risk minimization plan’ of the vaccines authorized for use?

Data availability statement

The data that support the findings reported in this study are available from the corresponding author [MD] upon reasonable request.